Products
Online Inquiry

Please note that we are not a pharmacy or clinic, so we are unable to see patients and do not offer diagnostic and treatment services for individuals.

Vitamin B12 test kit

Mogrol

Cat. No.: 0225LY-0969
Appearance: Solid
Purity: ≥99%
Identity: Confirmed by NMR, HPLC, and LC-MS.
Size:
Mogrol
Add to basket

Product Overview

Description: Mogrol is a metabolite of mogrosides that activates AMPK signaling while simultaneously inhibiting CREB activation and the STAT3 and ERK1/2 pathways.
Synonym: 88930-15-8; (3S,8S,9R,10R,11R,13R,14S,17R)-17-[(2R,5R)-5,6-dihydroxy-6-methylheptan-2-yl]-4,4,9,13,14-pentamethyl-2,3,7,8,10,11,12,15,16,17-decahydro-1H-cyclopenta[a]phenanthrene-3,11-diol; (10alpha,24R)-9beta-Methyl-19-norlanosta-5-ene-3beta,11alpha,24,25-tetrol; (23R)-cucurbit-5-ene-3beta,11alpha,23,25-tetraol; (24R)-cucurbit-5-ene-3beta,11alpha,24,25-tetraol; (1S,4R,9beta,11alpha,24R)-9,10,14-trimethyl-4,9-cyclo-9,10-secocholest-5-ene-1,11,24,25-tetrol; (1R,3aS,3bS,7S,9aR,9bR,10R,11aR)-1-[(2R,5R)-5,6-dihydroxy-6-methylheptan-2-yl]-3a,6,6,9b,11a-pentamethyl-1H,2H,3H,3bH,4H,7H,8H,9H,9aH,10H,11H-cyclopenta[a]phenanthrene-7,10-diol; (3S,8S,9R,10R,11R,13R,14S,17R)-17-((2R,5R)-5,6-dihydroxy-6-methylheptan-2-yl)-4,4,9,13,14-pentamethyl-2,3,7,8,10,11,12,15,16,17-decahydro-1H-cyclopenta(a)phenanthrene-3,11-diol
CAS No.: 88930-15-8
Compound CID: 14525327
Formula: C30H52O4
Formula Weight: 476.73

Specification

Relative Density: 1.10 g/cm3
Stability: 3 years in powder form.
Storage: Storage at -20°C.
Applications: Mogrol can be used in metabolic studies to examine its role as an AMPK activator in inhibiting lipid accumulation.

Library Information

Target: ERK; STAT; AMPK
Receptor: ERK1; ERK2; STAT3
Pathways: JAK/STAT signaling; MAPK; PI3K/Akt/mTOR signaling; Chromatin/Epigenetic; Stem cell regulation
Plate Number: AOCL-13
Plate Location: d10
Empty Location: a1-h1; a12-h12
Container: 96-well plate
Formulation: 10mM DMSO
DMSO Max Solubility: 110 mg/mL; 230.74 mM
Inquiry
0
Inquiry Basket

Copyright © Protheragen. All rights reserves.